FINAL PROGR AM - American Society of Gene & Cell Therapy
FINAL PROGR AM - American Society of Gene & Cell Therapy
FINAL PROGR AM - American Society of Gene & Cell Therapy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>AM</strong>ERICAN SOCIETY OF GENE THERAPY • Final Program 31<br />
SCIENTIFIC <strong>PROGR</strong><strong>AM</strong><br />
THURSDAY, JUNE 2, 2005<br />
Workshop 217<br />
Viral: Key Design Issues for Oncolytic Vectors<br />
Room: 240 Complex<br />
Chair: Samuel D. Rabkin, PhD<br />
Speakers: David L. Bartlett, MD - Options for Creating<br />
Mutant Poxviruses for Oncolytic <strong>Therapy</strong><br />
Noriyuki Kasahara, MD, PhD - Building a<br />
Better Mouse Virus: Design Strategies to Improve<br />
Therapeutic Efficacy and Safety <strong>of</strong> Replicationcompetent<br />
Retrovirus (RCR) Vectors for Cancer<br />
<strong>Gene</strong> <strong>Therapy</strong><br />
John C. Bell, PhD - VSV as an Oncolytic Agent<br />
Stephen J. Russell, MD, PhD - Retargeting<br />
Attachment and Entry <strong>of</strong> Oncolytic Viruses<br />
William S. M. Wold, PhD - Oncolytic<br />
Adenovirus Vectors that Overexpress ADP<br />
Samuel D. Rabkin, PhD - Oncolytic Herpes<br />
Simplex Virus (HSV) Vectors<br />
BREAK – 10:45 <strong>AM</strong> - 11:00 <strong>AM</strong><br />
WORKSHOPS – 11:00 <strong>AM</strong> - 12:30 PM<br />
Workshop 220<br />
Cardiovascular <strong>Gene</strong> <strong>Therapy</strong>: From Bench to Bedside<br />
Room: 120/124<br />
Co-Chairs: Anthony Rosenzweig, MD<br />
Roger J. Hajjar, MD<br />
Speakers: Albert J. Sinusas, MD - Imaging <strong>of</strong> Angiogenesis<br />
and <strong>Gene</strong> <strong>Therapy</strong> In Vivo<br />
R. Jude Samulski, PhD - Biological<br />
Nanoparticles: The Next <strong>Gene</strong>ration <strong>of</strong> Efficient<br />
Delivery Reagents<br />
David Kaye, FRACP, PhD, FACC -<br />
Percutaneous Approaches to Cardiac <strong>Gene</strong> Transfer<br />
Roger J. Hajjar, MD - The Road from<br />
Physiological Observation to <strong>Gene</strong> <strong>Therapy</strong> in<br />
Patients with Heart Failure<br />
Workshop 221<br />
Clinical and Regulatory Affairs: <strong>Cell</strong> and <strong>Gene</strong> Based<br />
Cancer Vaccines<br />
Room: 263/267<br />
Chair: Dale Ando, MD<br />
Speakers: Karin Jooss, PhD - Combination <strong>Therapy</strong> <strong>of</strong> a<br />
GM-CSF Secreting Tumor <strong>Cell</strong> Vaccine and<br />
anti-CTLA-4: Preclinical Evaluation and Tox<br />
Studies<br />
Drew Pardoll, MD, PhD - Targeting Immune<br />
Responses to Sites <strong>of</strong> Cancer Using Engineered<br />
Viruses and Bacteria<br />
Stephen J. Russell, MD, PhD - Noninvasive<br />
Expression Monitoring <strong>of</strong> Oncolytic Viruses in<br />
Phase I Clinical Trials<br />
Workshop 222<br />
<strong>Gene</strong>tic Diseases: Focus on the Metabolic Diseases <strong>of</strong><br />
the Liver<br />
Room: 265/266<br />
Chair: Jayanta Roy-Chowdhury, MD<br />
Speakers: Markus Grompe, MD - Strategies to Select<br />
Hepatocytes In Vivo<br />
Cary Harding, MD - <strong>Gene</strong> and <strong>Cell</strong>-mediated<br />
Therapeutic Approaches to Phenyckeonuria<br />
Jayanta Roy-Chowdhury, MD - SV40-based<br />
Vectors for Metabolic Diseases <strong>of</strong> the Liver and<br />
Beyond<br />
Brendan Lee, MD, PhD - Helper-dependent<br />
Adenoviral <strong>Gene</strong> <strong>Therapy</strong> for Metabolic Liver<br />
Diseases<br />
Workshop 223<br />
Infectious Disease: Innate Immunity and Vector<br />
Function<br />
Room: 123/127<br />
Co-Chairs: Bruce L. Levine, PhD<br />
John A. Zaia, MD<br />
Speakers: Hildegund CJ Ertl, MD - Innate Immunity to<br />
Adenovirus<br />
Bryan Williams, PhD - Synergistic Activation <strong>of</strong><br />
Innate Immunity by Double-stranded RNA and<br />
CpG DNA<br />
Bruce E. Torbett, PhD, MSPH - Are<br />
Viral-based Vectors and Their Payloads Seen as<br />
Pathogens?<br />
Hua Yu, PhD - Stat3 Targeting and Immunity